Compugen Ltd (Israel) Profile

1,274
ILS 86.00  7.24%
33%

Compugen Ltd Summary

Compugen Ltd (CGEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Azrieli Center and employs 101 people. The company currently falls under 'Small-Cap' category with current market capitalization of 705.22 M. Compugen Ltd operates under Healthcare sector and is part of Biotechnology industry. This company has 57.2 M outstanding shares. COMPUGEN has accumulated about 42.46 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74.
Check Compugen Ltd Probability Of Bankruptcy

Compugen Ltd Target Price Odds Analysis

Odds Below 1274.0HorizonTargetOdds Above 1274.0
16.92%30 days 1,274 82.92%
Based on normal probability distribution, the odds of Compugen Ltd to move above current price in 30 days from now is about 82.92% (This Compugen Ltd probability density function shows the probability of Compugen Ltd Stock to fall within a particular range of prices over 30 days) .

Compugen Ltd Top Holders

Compugen Ltd Income Statement Over Time

Net Income    Revenues    

Compugen Ltd Key Fundamentals

Compugen Ltd Current Ratings

Compugen Ltd 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
48 
Equity ratings for Compugen Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 101 people. more
NameCompugen Ltd
President CEO, DirectorAnat CohenDayagView All
Macroaxis Advice
InstrumentIsrael Stock View All
RegionMiddle East
Business AddressAzrieli Center
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
CIK Number0001119774
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cgen.com
Phone972 3 765 8585
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017

Compugen Ltd Directors

Compugen Ltd Corporate Directors

Joshua Shemer Independent External Director
Michal Preminger Director
Dov Hershberg Director
Check also Trending Equities. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Search macroaxis.com